Iraklis Petrof, PhD
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Skip to content
Research Administration Fellowship, Clinical Research Administration - Children's Hospital of Philadelphia, Philadelphia, PA
BSc in Psychology - University of Wales, Bangor, United Kingdom
PhD in Psychology/Behavioral Neuroscience - University of St Andrews, St Andrews, United Kingdom
Fu C-H, Iascone DM, Petrof I, Hazra A, Zhang X, Pyfer MS, Tosi U, Corbett BF, Cai J, Lee J, Park J, Iacovitti L, Scharfmann HE, Enikolopov G, Chin J (2019). Early seizure activity accelerates depletion of hippocampal neural stem cells and impairs spatial discrimination in an Alzheimer’s disease mouse model. Cell Reports, 27(13):3741-3751.
Yun S, Reynolds RP, Petrof I, White A, Rivera PD, Segev A, Gibson AD, Suarez M, Desalle MJ, Ito N, Mukherjee S, Richardson DR, Kang CE, Soler I, Chetkovich DM, Kourrich S, Coulter DA, Eisch AJ (2018). Stimulation of entorhinal cortex-dentate gyrus circuitry is antidepressive. Nature Medicine 24:258-266.
You J, Park J, Muralidharan K, Petrof I, Pyfer MS, Corbett BF, LaFrancois J, Zheng Y, Zhang X, Mohila C, Yoshor D, Rissman R, Nestler E, Scharfman H, Chin J (2017). Epigenetic suppression of hippocampal calbindin-D28k by ΔFosB drives seizure-related cognitive deficits. Nature Medicine 23(11):1377-1383.
Mo C*, Petrof I*, Viaene A, Sherman SM (2017). Synaptic properties of the lemniscal and paralemniscal pathways to the mouse somatosensoty cortex. PNAS 114(30): E6212-6221. *Authors contributed equally
Corbett B, You J, Zhang X, Pyfer M, Tosi U, Iascone D, Petrof I, Hazra H, Fu A, Ashok A, Aschmies S, Zhao L, Neslter EJ, Chin J (2017). ΔFosB mediates epigenetic suppression of cFos expression in models of epilepsy and Alzheimer’s disease. Cell Reports 20(2):344-355.
Liu T, Petrof I & Sherman SM (2015) Modulatory effects of metabotropic glutamate receptors activation on GABAergic circuits in mouse thalamus. J Neurophys. 113(7) 2646-52
Petrof I, Viaene AN & Sherman SM (2015) Properties of the primary somatosensory cortex projection to primary motor cortex in the mouse. J Neurophys. 113(7) 2400-7
Liu T, Petrof I & Sherman SM (2014). Modulatory effects of activation of metabotropic glutamate receptors on GABAergic circuits in the mouse cortex. J Neurophys. 111(11): 2287-97
Petrof I & Sherman SM (2013). Functional significance of synaptic terminal size in glutamatergic sensory pathways in thalamus and cortex. J Phys. 591(13):3125-31
Viaene AN, Petrof I & Sherman SM (2013). Activation requirements for metabotropic glutamate receptors. Neurosci Lett. 541:67-72
Petrof I, Viaene AN & Sherman SM (2012). Two populations of corticothalamic and interareal corticocortical cells in the subgranular layers of the mouse primary sensory cortices. J Comp Neurol. 520(8):1678-86
Viaene AN, Petrof I & Sherman SM (2011). Properties of the thalamic projection from the posterior medial nucleus to primary and secondary somatosensory cortices in the mouse. PNAS. 108(44):18156-18161
Viaene AN, Petrof I & Sherman SM (2011). Synaptic properties of thalamic input to the subgranular layers of primary somatosensory and auditory cortices in the mouse. J Neurosci. 31(36):12738-47
Viaene AN*, Petrof I* & Sherman SM (2011). Synaptic properties of thalamic input to layers 2/3 and 4 of primary somatosensory and auditory cortices. J Neurophys. 105(1):279-92 *Authors contributed equally
Petrof I & Brown VJ (2010). Attention to visual, but not tactile, properties of a stimulus results in activation of FOS protein in the visual thalamic reticular nucleus of rats. Beh Br Res. 211(2)-248-252
Petrof I & Sherman SM (2009). Synaptic properties of the mammillary and cortical afferents to the anterodorsal thalamic nucleus in the mouse. J Neurosci. 29(24):7815-9
Petrof I & Marí-Beffa P (2005). Flanker-like interference and response-based mechanisms of selective attention. An ERP study. The Psychologist in Wales / Y Seicolegydd yng Nghymru. 18: 35-42
2015-present, Editorial Board, Journal of Neurology and Experimental Neural Science
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.